Status:
COMPLETED
Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical Wards
Lead Sponsor:
St George's, University of London
Conditions:
COPD
Hyperglycemia
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
Patients with chronic obstructive pulmonary disease (COPD) are commonly admitted to hospital with exacerbations of their lung disease. A combination of the acute illness and treatment with oral steroi...
Eligibility Criteria
Inclusion
- Physician diagnosis of AECOPD as primary cause for admission
- Able to enter study within 24 hours of admission
Exclusion
- Intensive care unit admission
- Moribund or not for active treatment
- Admission expected to last \<48 hours
- Unable or unwilling to give informed consent
- Known Type I diabetes mellitus
- Patients with reduced awareness of hypoglycaemia including reduced Glasgow coma scale or those taking beta blockers
- Patients with renal or hepatic failure at increased risk of hypoglycaemia
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00764556
Start Date
May 1 2008
End Date
May 1 2009
Last Update
October 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St George's Healthcare NHS Trust
London, United Kingdom, SW17 0RE